Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Adv ; 6(41)2020 10.
Article in English | MEDLINE | ID: mdl-33036964

ABSTRACT

Food security in a warming world is a grave concern for rapidly growing impoverished populations. Low-latitude inland fisheries provide protein for millions of rural poor, yet the impacts of high-frequency climate oscillations on these aquatic ecosystems are unknown. Here, we present a sub-annual-to-annual resolution paleolimnological reconstruction of upwelling, productivity, and algal composition at Lake Tanganyika, one of Africa's largest landlocked fisheries. The data reveal increases in diatom production at centennial-scale solar irradiance maxima, and interannual variability in upwelling linked to La Niña. Our study shows that interactions between global climatic controls and El Niño-Southern Oscillation teleconnections exert profound influences on the foundation of Lake Tanganyika's food web. Adapting long-term management practices to account for high-frequency changes in algal production will help safeguard inland fish resources.

2.
J Clin Invest ; 130(11): 5721-5737, 2020 11 02.
Article in English | MEDLINE | ID: mdl-32721948

ABSTRACT

Women with dense breasts have an increased lifetime risk of malignancy that has been attributed to a higher epithelial density. Quantitative proteomics, collagen analysis, and mechanical measurements in normal tissue revealed that stroma in the high-density breast contains more oriented, fibrillar collagen that is stiffer and correlates with higher epithelial cell density. microRNA (miR) profiling of breast tissue identified miR-203 as a matrix stiffness-repressed transcript that is downregulated by collagen density and reduced in the breast epithelium of women with high mammographic density. Culture studies demonstrated that ZNF217 mediates a matrix stiffness- and collagen density-induced increase in Akt activity and mammary epithelial cell proliferation. Manipulation of the epithelium in a mouse model of mammographic density supported a causal relationship between stromal stiffness, reduced miR-203, higher levels of the murine homolog Zfp217, and increased Akt activity and mammary epithelial proliferation. ZNF217 was also increased in the normal breast epithelium of women with high mammographic density, correlated positively with epithelial proliferation and density, and inversely with miR-203. The findings identify ZNF217 as a potential target toward which preexisting therapies, such as the Akt inhibitor triciribine, could be used as a chemopreventive agent to reduce cancer risk in women with high mammographic density.


Subject(s)
Breast Neoplasms , Mammary Glands, Human , Oncogene Proteins/metabolism , Trans-Activators/metabolism , Adult , Animals , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Double-Blind Method , Female , Humans , Mammary Glands, Human/metabolism , Mammary Glands, Human/pathology , Mice , MicroRNAs/metabolism , Middle Aged , Proto-Oncogene Proteins c-akt/metabolism , RNA, Neoplasm/metabolism , Risk Factors
3.
Front Cell Dev Biol ; 6: 17, 2018.
Article in English | MEDLINE | ID: mdl-29541636

ABSTRACT

The tumor microenvironment is a dynamic landscape in which the physical and mechanical properties evolve dramatically throughout cancer progression. These changes are driven by enhanced tumor cell contractility and expansion of the growing tumor mass, as well as through alterations to the material properties of the surrounding extracellular matrix (ECM). Consequently, tumor cells are exposed to a number of different mechanical inputs including cell-cell and cell-ECM tension, compression stress, interstitial fluid pressure and shear stress. Oncogenes engage signaling pathways that are activated in response to mechanical stress, thereby reworking the cell's intrinsic response to exogenous mechanical stimuli, enhancing intracellular tension via elevated actomyosin contraction, and influencing ECM stiffness and tissue morphology. In addition to altering their intracellular tension and remodeling the microenvironment, cells actively respond to these mechanical perturbations phenotypically through modification of gene expression. Herein, we present a description of the physical changes that promote tumor progression and aggression, discuss their interrelationship and highlight emerging therapeutic strategies to alleviate the mechanical stresses driving cancer to malignancy.

4.
J Pharmacol Exp Ther ; 333(1): 23-33, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20086055

ABSTRACT

Prenylation inhibitors have gained increasing attention as potential therapeutics for cancer. Initial work focused on inhibitors of farnesylation, but more recently geranylgeranyl transferase inhibitors (GGTIs) have begun to be evaluated for their potential antitumor activity in vitro and in vivo. In this study, we have developed a nonpeptidomimetic GGTI, termed GGTI-2Z [(5-nitrofuran-2-yl)methyl-(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl 4-chlorobutyl(methyl)phosphoramidate], which in combination with lovastatin inhibits geranylgeranyl transferase I (GGTase I) and GGTase II/RabGGTase, without affecting farnesylation. The combination treatment results in a G(0)/G(1) arrest and synergistic inhibition of proliferation of cultured STS-26T malignant peripheral nerve sheath tumor cells. We also show that the antiproliferative activity of drugs in combination occurs in the context of autophagy. The combination treatment also induces autophagy in the MCF10.DCIS model of human breast ductal carcinoma in situ and in 1c1c7 murine hepatoma cells, where it also reduces proliferation. At the same time, there is no detectable toxicity in normal immortalized Schwann cells. These studies establish GGTI-2Z as a novel geranylgeranyl pyrophosphate derivative that may work through a new mechanism involving the induction of autophagy and, in combination with lovastatin, may serve as a valuable paradigm for developing more effective strategies in this class of antitumor therapeutics.


Subject(s)
Alkyl and Aryl Transferases/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Autophagy , Diterpenes/pharmacology , Lovastatin/pharmacology , Organophosphorus Compounds/pharmacology , Transferases/antagonists & inhibitors , Animals , Apoptosis , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Drug Synergism , G1 Phase/drug effects , GTP Phosphohydrolases/metabolism , Humans , Mice , Protein Prenylation , Resting Phase, Cell Cycle/drug effects , Schwann Cells/cytology , Schwann Cells/drug effects
5.
Neuropsychologia ; 37(7): 817-28, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10408649

ABSTRACT

This study assessed the verbal memory functions of 20 patients with idiopathic Parkinson's Disease (PD) without any clinical evidence of dementia and 20 Medical Control (MC) patients with similar levels of physical disability. Performance was compared on tests of immediate recall, word list learning in intentional and incidental contexts, word completion priming, remote memory, metamemory and awareness of mnestic abilities. Significant differences were found in new learning of verbal material under incidental but not intentional learning conditions. Group differences were also observed on measures of remote memory and metamemory. The groups did not differ in word completion priming performance or recognition memory. These findings are consistent with other evidence suggesting that PD patients without dementia may have subtle cognitive deficits that affect memory performance. These may be attributable to impairments of attention allocation, formulation of retrieval strategies, and effortful learning associated with frontal lobe dysfunction. The group differences could not be attributed to impairments of intellectual functions, verbal fluency, level of physical disability, or mood disturbance.


Subject(s)
Memory Disorders/diagnosis , Memory Disorders/etiology , Mental Processes , Parkinson Disease/complications , Parkinson Disease/psychology , Verbal Learning , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Intelligence Tests , Male , Middle Aged , Word Association Tests
6.
Blood ; 75(2): 499-504, 1990 Jan 15.
Article in English | MEDLINE | ID: mdl-1688505

ABSTRACT

The gamma-globin genes from a patient homozygous for a deletion form of hereditary persistence of fetal hemoglobin (HPFH-1) have been cloned and sequenced. The DNA sequence of the patient's gamma-globin genes corresponds to a previously identified sequence framework (chromosome A) with the exception of 10 base changes. Seven of these base changes can be attributed to normal allelic variation generated by small gene conversion events. The remaining three base changes are present in a 0.76 kb HindIII fragment containing a putative enhancer located 3' to the A gamma-globin gene. The same three base changes have also been described in the Seattle variant of nondeletion HPFH. We have analyzed 16 alleles from non-HPFH individuals and five alleles from individuals with nondeletion or deletion HPFH for the presence of these base changes by polymerase chain reaction amplification of cloned or chromosomal DNA and hybridization to allele-specific oligonucleotide probes. Although these base changes were found in an individual with HPFH-2, they were not found in the DNA from two patients with nondeletion HPFH. More importantly, all three base changes were detected in DNA from five non-HPFH individuals and appear to be common in blacks. We conclude that these base changes do not correlate with an HPFH phenotype and that the significant mutation in HPFH-1 is the deletion of over 100 kb of genomic DNA.


Subject(s)
Fetal Hemoglobin/genetics , Globins/genetics , Hemoglobinopathies/genetics , Base Sequence , Chromosome Deletion , Cloning, Molecular , Genes , Humans , Nucleic Acid Hybridization , Oligonucleotide Probes , Polymerase Chain Reaction , Restriction Mapping
7.
J Virol ; 53(3): 893-8, 1985 Mar.
Article in English | MEDLINE | ID: mdl-2983099

ABSTRACT

Treatment of African green monkey kidney CV-1 cells with human alpha interferons before infection with simian virus 40 (SV40) inhibited the accumulation of SV40 mRNAs and SV40 T-antigen (Tag). This inhibition persisted as long as the interferons were present in the medium. SV40-transformed human SV80 cells and mouse SV3T3-38 cells express Tag, and interferon treatment of these cells did not affect this expression. SV80 and SV3T3-38 cells which had been exposed to interferons were infected with a viable SV40 deletion mutant (SV40 dl1263) that codes for a truncated Tag. Exposure to interferons inhibited the accumulation of the truncated Tag (specified by the infecting virus) but had no significant effect on the accumulation of the endogenous Tag (specified by the SV40 DNA integrated into the cellular genome). The level of Tag in SV40-transformed mouse SV101 cells was not significantly decreased by interferon treatment. SV40 was rescued from SV101 cells and used to infect interferon-treated and control African green monkey kidney Vero cells. Tag accumulation was inhibited in the cells which had been treated with interferons before infection. Our data demonstrate that even within the same cell the interferon system can discriminate between expression of a gene in the SV40 viral genome and expression of the same gene integrated into a host chromosome.


Subject(s)
Cell Transformation, Viral , Interferon Type I/pharmacology , Simian virus 40/drug effects , Animals , Cell Line , Chlorocebus aethiops , Genes, Viral , Humans , Mice , RNA, Messenger/analysis , Simian virus 40/genetics , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...